Human Papillomavirus (2025)
UK Health Security Agency · awarded 10 October 2025
£1
Award value
£1
1
Supplier
Recorded as a large business
30 Nov 2029
Runs until
from 1 Dec 2025
Who
| Buyer | UK Health Security Agency London |
|---|---|
| Supplier |
Merck Sharpe & Dohme (UK) Limited |
| Category | goods |
| Classification | Vaccines CPV 33651600 |
| Notice published | 16 October 2025 |
What it is for
Contract for the supply of human papillomavirus vaccine to be used as part of the national immunisation programme. Deliveries will be required for a four year period from December 2025 Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.
Read the original award notice on Contracts Finder →
Other contracts from this buyer
540 awards on file, worth £872.1m.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 1 Jun 2026 | Live Attenuated Influenza vaccine 2026/2027 | UK Health Security Agency | ASTRAZENECA UK LIMITED | £225.4m |
| 18 Jan 2022 | Single Service Centre - HGS | UK Health Security Agency | HINDUJA GLOBAL SOLUTIONS UK LIMITED | £211.9m |
| 3 Dec 2025 | Select Item 1 UKHSA Trust Programme Delivery Partner | UK Health Security Agency | PA CONSULTING SERVICES LIMITED | £29.6m |
| 18 Sep 2024 | Enterprise Data Platform Delivery partner | UK Health Security Agency | KAINOS SOFTWARE LIMITED | £18.0m |
| 18 Sep 2024 | Enterprise Data Platform Delivery partner | UK Health Security Agency | KAINOS SOFTWARE LIMITED | £18.0m |
Everything UK Health Security Agency has awarded →
Other contracts won by this supplier
5 awards on file, worth £1.0bn.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 28 Oct 2024 | NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024 | NHS England | Gilead Sciences Limited +12 | £626.5m |
| 22 Jul 2024 | NHS Branded Medicines Tranche Framework for London and South of EnglandEast Midlands | NHS England | Sun Pharma UK Ltd +28 | £381.0m |
| 10 Oct 2025 | Human Papillomavirus (2025) | UK Health Security Agency | Merck Sharpe & Dohme (UK) Limited | £1 |
| 10 Oct 2025 | Human Papillomavirus (2025) | UK Health Security Agency | Merck Sharpe & Dohme (UK) Limited | £1 |
| 7 Aug 2025 | Measles, Mumps, Rubella and Varicella (MMRV) vaccine (2025) | UK Health Security Agency | Merck Sharpe & Dohme (UK) Limited +1 | £1 |